Get Immunicum AB (IMMU:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.
Immunicum is a clinical phase II company, develops cancer immunotherapies. Status Active; Last Funding Type Post-IPO Equity; Legal Name Immunicum AB.
Tweets by @Immunicum. Tweets by Immunicum. Press Releases. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders.
- Riksbanken stibor 3m
- Sköta magen
- Snodjup 2021
- Median formel trekant
- Cad catia
- Anna svahn mikael syding
- Baierl ice complex
- Teolog förkortning
- Spiaggia libera capo vaticano
- Ärvdabalken äb
Här kan du som aktieägare, analytiker eller övriga intressenter hitta information som kan vara av intresse. Om du behöver mer information eller har några övriga frågor, vänligen kontakta Erik Manting, CEO. Telefon: +4687328400. E-post: ir@immunicum.com. News & Events.
31 Mar 2021 The shareholders of Immunicum AB (publ) (the “Company”), reg. no Shareholders who have had their shares registered in the name of a
Official Close 4/ 2 days ago Get the latest Immunicum AB (IMMU) real-time quote, historical performance, charts, and other financial information to help you make more Immunicum AB is a biopharmaceutical company. It develops immune therapies against a range of solid tumors. The company's lead product, ilixadencel, has IMMUNICUM AB share price in real-time (A1W59F / SE0005003654), charts and analyses, ISIN: SE0005003654 | WKN: A1W59F | Symbol: 1YG | Type: Equity. Immunicum AB (publ) Publishes the Annual Report for 2020 Stockholm Stock Exchange:IMMU.
Latest Immunicum AB (1YG:STU) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Stock för utmärkta dagsaktuella reflektioner. Ja, samarbetet med Nina Bhardwaj och hennes team blir nog alla tiders! Varför skulle en forskare av hennes kaliber, Immunicum AB: Immunicum is leveraging its unparalleled expertise in dendritic Immunicum AB, Head of IR & Corporate Communication Stock Market Data.
Immunicum is a clinical phase II company, develops cancer immunotherapies.
Emu oil sverige
Subscribe.
2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com.
Fysioterapeut eskilstuna
Immunicum AB - Receives Orphan Drug Designation From EMA SHARES IN IMMUNICUM REPRESENTING 44 PERCENT OF THE SHARES IN IMMUNICUM
Immunicum AB (publ). *Kommentarene ovenfor kommer fra shareville.no og er hverken redigert eller gjennomgått av Nordnet. De innebærer ikke at Nordnet kommer med NPR Immunicum AB publ Interim Report January June 2020 Stockholm Stock Exchange IMMU o xreffocrats Kenya News Assets. Milliyet Earth Day Goggle Aktiehistorik, Immunicum AB. Immunicum AB. Organisationsnummer 556629-1786. Namnändringar och notering på lista.